Improving patient engagement and retention while reducing burden with scalable, adaptable decentralized trials.
This white paper discusses ways to take patient preferences and needs into consideration during the design and delivery of clinical trials, resulting in greater efficiency and patient engagement.
The COVID-19 clinical trials helped the industry get more comfortable with the idea of using decentralized clinical trial (DCT) approaches – including remote patient engagement, connected devices and specialized DCT study team roles – for future clinical trials. They also underscored the need for more intentional patient centricity to keep patients engaged in the trial experience.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings